pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

284 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT785Endpoints586BioPharma Dive224onclive165BioSpace60Fierce Biotech59raps24
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology6Hematology
  • Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drug
    <figure><div><img src="https://imgproxy.divecdn.com/xFVDAUb89QQFVPrJL8faaWdXxcY16WqAOJqd9TV5Hi0/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzY5MDAzNjAwLmpwZ…
    BioPharma Dive · 2mo ago↗ source
  • Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billion
    <figure><div><img src="https://imgproxy.divecdn.com/d3kyAOKiV4alroZs496u4_W_RA0u2QbwRQbzfwY4ALY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNjg5NTg1NDg3X3JmN…
    BioPharma Dive · 2mo ago↗ source
  • A year after Vertex’s big launch, pain drug research faces a pivotal moment
    <p>Journavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?</p>
← prev
page 10 of 12
next →
6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
BioPharma Dive · 2mo ago
↗ source
  • GSK cuts deal with Sino to broaden reach of hepatitis B drug
    <figure><div><img src="https://imgproxy.divecdn.com/mDk-h3NLB8udDPFuDlI7IPou1i9tJKJYucQXUnhK9vA/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTc3MzEzMjc4LmpwZ…
    BioPharma Dive · 2mo ago↗ source
  • Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 2mo ago↗ source
  • Biotech layoffs are easing, but is the worst over?
    <figure><div><img src="https://imgproxy.divecdn.com/TL3Qf7mHRlVjEhCJI35ocLIfavZ0TUEHiNIVNf4xjm8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9TY3JlZW5zaG90XzIwMjYtMDUtMDdfYXRfM…
    BioPharma Dive · 2mo ago↗ source
  • Precision in motion: Decoding the critical operations behind the logistics of next-generation cell and gene therapies
    <p>The future of medicine is here. See how specialized logistics are saving lives with next-gen cell and gene therapies.</p>
    BioPharma Dive · 2mo ago↗ source
  • The capacity crunch in biopharma is a location problem
    <p>Cell and gene therapies aren’t limited by ideas—they’re limited by where they’re built. See how “ready-now” locations change the math on scaling.</p>
    BioPharma Dive · 2mo ago↗ source
  • Lilly to invest extra $4.5B across Indiana manufacturing
    <figure><div><img src="https://imgproxy.divecdn.com/8nTrHlsFTcngJswJxr_8afos9dxh_YxQE6LZmgMA2_I/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMDkyNDczMjEzX2VHa…
    BioPharma Dive · 2mo ago↗ source
  • FDA to reevaluate spurned cell therapy; Under-the-skin Leqembi review extended
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 2mo ago↗ source
  • Lilly, Gilead lead pharma’s M&A boom
    <figure><div><img src="https://imgproxy.divecdn.com/wW2Sw-v1m2RoAnzb6Llg6MP71MxLlDb61aNlxns-F98/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjIxODc5NzA5X2RKS…
    BioPharma Dive · 2mo ago↗ source
  • Odyssey, on second try, snags $279M in an IPO
    <figure><div><img src="https://imgproxy.divecdn.com/szYDL8kkQd6XaSVgvjJPYl2j0snveijWs_0sZ-B522Y/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDYyODUzODA3LmpwZ…
    BioPharma Dive · 2mo ago↗ source
  • Sarepta tumbles as its gene therapy sales decline further
    <figure><div><img src="https://imgproxy.divecdn.com/XaTqfcte0RAZt6-RIcgWQ5i2KmL-mKKasPXR8xjfQW8/g:nowe:0:858/c:4256:2405/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9TYXJlcHRhX0Jvc…
    BioPharma Dive · 2mo ago↗ source
  • Angelini to buy Catalyst in $4B play for rare neuro drugs
    <figure><div><img src="https://imgproxy.divecdn.com/4_eQ3BQP0sHe3AjR5s7bySznoaDhyqMpmhkmNubOdkU/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDQwMTY4MDMyXzEua…
    BioPharma Dive · 2mo ago↗ source
  • Entrada shares dive as Duchenne results disappoint
    <figure><div><img src="https://imgproxy.divecdn.com/xa_T0oT9Hj8F-wJjKfJeFkbn4Yqp_lT58dL0S4GszxY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy02MjEzNjQ4MDJfMS5qc…
    BioPharma Dive · 2mo ago↗ source
  • Roche to acquire digital pathology firm PathAI in deal potentially worth over $1B
    <figure><div><img src="https://imgproxy.divecdn.com/Q9vt9_gxDkyyl1zgpo6ZBBNf6InJ95ZMxSRGRm4nTFk/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS8yQTROWEtOLmpwZw==.webp"/></div></f…
    BioPharma Dive · 2mo ago↗ source
  • Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipeline
    <figure><div><img src="https://imgproxy.divecdn.com/gRkyNZ1AbgGTL_5MqeKhbG0YuhnzTHcUYxQb5ULTKUc/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMjA4MzAxNTQ0LmpwZ…
    BioPharma Dive · 2mo ago↗ source
  • Novo hikes guidance on Wegovy pill’s fast sales start
    <p>In its latest earnings report, the Danish drugmaker said sales and profit should shrink less than the company originally anticipated thanks to strong prescription numbers for its new obesity pil…
    BioPharma Dive · 2mo ago↗ source
  • Avalo shares spike on skin drug data; BioNTech to cut staff
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 2mo ago↗ source
  • CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine
    <figure><div><img src="https://imgproxy.divecdn.com/aUhcesS0eCO3NThNNqPfIC_gM2-0lSalzL7WEg-RP7g/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy02ODA4MDQ3ODAuanBn.…
    BioPharma Dive · 2mo ago↗ source
  • Viridian data lift prospects for thyroid eye disease drug
    <figure><div><img src="https://imgproxy.divecdn.com/egbyTu8esim-VjYj5FTvMQUlBrndW-s35OSn02s-EoY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzk4NTE5MTYzLmpwZ…
    BioPharma Dive · 2mo ago↗ source
  • Vertex earnings get muted investor response
    <p>While overall revenue fell just shy of Wall Street forecasts, sales of the gene editing medicine Casgevy and pain drug Journavx missed analyst estimates by double-digit percentages.</p>
    BioPharma Dive · 2mo ago↗ source
  • Cytokinetics heart drug scores in closely watched trial
    <figure><div><img src="https://imgproxy.divecdn.com/O5l3Ak2w-ITPZwAy2_UP-yuYAxNqpRx2E-yOxBQdi8M/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy05MzA1MTIzNTAuanBn.…
    BioPharma Dive · 2mo ago↗ source
  • Cytospire hauls in $83M for a new type of T cell engager
    <p>The British biotechnology startup is making "pan-gamma delta” T cell engagers it says can address the limitations of similar, existing therapies. </p>
    BioPharma Dive · 2mo ago↗ source
  • Celcuity strengthens case for ASCO-spotlighted breast cancer drug
    <figure><div><img src="https://imgproxy.divecdn.com/1TNhYQTUI7yObB637nFZIAJqv_C_vHe6B8CqUtpkWHg/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMTQwMTQ3MDc2LmpwZ…
    BioPharma Dive · 2mo ago↗ source